CURE Pharmaceutical Holding Corp. (OTC: CURR), a proprietary broad platform and wellness technology company, today announced results for the quarter ended June...
The article Mydecine Sells Mindleap Health for $4 Million was originally published on Microdose. We’ve been reporting on the apparent troubles over...
Mydecine sells Mindleap and gets a much-needed cash infusion. The post Mydecine Sells Mindleap For C$4 Million appeared first on Green Market Report.